News

Vaccination was cost saving for participants aged 65 years and older. In phase 2 analyses, an additional dose was ...
Clinical trials have shown the mRNA vaccines for COVID-19 are safe and effective, especially at preventing severe illness, ...
The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...
There have been no changes to the licensing and royalty agreements related to mRNA research that have netted the university ...
Jerome Adams, the U.S. Surgeon General under President Trump's first term, is criticizing his administration's cuts to mRNA ...
HHS says the elimination of 22 mRNA vaccine development projects for COVID-19 and bird flu signals a shift in vaccine ...
On Tuesday, the US Department of Health and Human Services disclosed the end of funding for 22 mRNA vaccine projects — a ...
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...